MDI Therapeutics

MDI Therapeutics

Developing novel oral therapies targeting fibrosis and fibroproliferative diseases.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round

$9.0m

Series A
Total Funding000k
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads